
Selected publications from PubMed
Microalbuminuria, another use for paricalcitol? Our experience in advanced chronic kidney disease.
Blanco-García R, Bravo-López JJ, Moreiras-Plaza M, Nájera-de la Garza W, Cossio-Annibar C, Beato-Coo L, Rodríguez-Goyanes G
Nefrologia. 2012 May 14;32(3):401-2 doi: 10.3265/Nefrologia.pre2012.Feb.11378.
Abandonment of peritoneal dialysis due to peritonitis: Have the responsible agents changed? Our experience.
Blanco-García R, Nájera-de la Garza W, Moreiras-Plaza M, Bravo-López JJ, Rodríguez-Goyanes G, Cossio-Anibar C, Beato-Coo L
Nefrologia. 2012;32(6):845-6 doi: 10.3265/Nefrologia.pre2012.Jun.11496.
[Kidney failure and diabetes. Diagnostic inertia?].
Blanco García R, Bravo López JJ, Pérez A, Moreiras Plaza M
Nefrologia. 2010;30(6):712-3 doi: 10.3265/Nefrologia.pre2010.Oct.10679.
[HTA-pre-eclampsia-postpartum haemolytic-uraemic syndrome: good results can be achieved].
Santos Nores J, Bravo López JJ, Borrajo Prol MP, Iglesias Forneiro A
Nefrologia. 2010;30(5):593-4 doi: 10.3265/Nefrologia.pre2010.Jun.10479.
[Peritoneal dialysis after catheter removal in peritonitis].
Santos Nores J, Camba Caride M, Bravo López JJ, Perez Melón C
Nefrologia. 2009;29(5):500-1 doi: 10.3265/Nefrologia.2009.29.5.5433.en.full.
Help your network discover Dr. Jorge Bravo López's clinical expertise.